Quick Answer
REVELATION BIOSCIENCES, INC. reported Operating Income Loss of -$9.07 million for the year ending 2025.
- REVELATION BIOSCIENCES, INC. showed a decrease of -13.7% in Operating Income Loss from 2024 to 2025.
- This data is from REVELATION BIOSCIENCES, INC.'s annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2021 to 2025 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 5 years of available data (2021 to 2025), REVELATION BIOSCIENCES, INC.'s Operating Income Loss has grown by 24.1%.
- Historical annual values: Fiscal year 2025: -$9.07 million | Fiscal year 2024: -$7.98 million | Fiscal year 2023: -$8.66 million | Fiscal year 2022: -$10.86 million | Fiscal year 2021: -$11.95 million.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: